Welcome to Optimus

Optimus is one of the fastest-growing pharmaceutical companies with 16 years of experience in providing the best quality of API, Intermediates & Finished formulations in Global markets. Our aim from day one has been to provide and ensure better healthcare across the globe through our research, Innovations, affordable products & manufacturing excellence.

Optimus is now part of Sekhmet Pharmaventures.

Read more Visit Sekhmet Pharmaventures

17 Years of Excellence

1300+

Qualified Staff

100+

Products

40+

Countries

17+

Years of Experience

Capabilities

  • Our Range of Experts stands by competence in synthetic chemistry, method development, validation, tech transfer, and scale-up activities.
  • Understanding of IPR & Regulatory Criteria and ability to develop non-infringing process.
  • Deliver high quality & affordable products in the global market through R&D and manufacturing excellence.

Pillars of Optimus

Research and Development

Research and Development

Standalone R&D lab with 150+ scientists, strong API & formulation knowledge.

Integration

Integration

Backward integration with intermediate & API manufacturing for quality and competitiveness.

Product Focus

Product Focus

Developing complex, niche molecules based on market demand and future potential.

Scalability

Scalability

Delivering from gram scale to multi-ton levels, core competence in scale-up.

Quality Policy

Quality Policy

Maintaining best quality standards in R&D and manufacturing through stringent policies.

Global Presence

  • Nigeria
  • South Africa
  • Tunisia
  • Belarus
  • Russia
  • Azerbaijan
  • Uzbekistan
  • Kazakhstan
  • Albania
  • Austria
  • Croatia
  • Cyprus
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Malta
  • Netherlands
  • Poland
  • Romania
  • Slovenia
  • Spain
  • Switzerland
  • Ukraine
  • United Kingdom
  • Argentina
  • Chile
  • Colombia
  • Costa Rica
  • Cuba
  • Mexico
  • Uruguay
  • Algeria
  • Egypt
  • Iran
  • Israel
  • Jordan
  • Lebanon
  • Saudi Arabia
  • Syria
  • Tunisia
  • Turkey
  • UAE
  • Canada
  • El Salvador
  • USA
  • Indonesia
  • Malaysia
  • Myanmar
  • Vietnam
  • Philippines
  • Cambodia
  • Japan
  • China
  • Taiwan
  • South Korea
  • Singapore
  • Bangladesh
  • India
  • Nepal
  • Pakistan

Latest News

MOLNUPIRAVIR

Optimus Pharma receives restricted emergency use Authorization for Molnupiravir in india.

Read more

Production Linked Incentive

Optimus Drugs and Optimus Pharma Pvt Ltd. qualified for the Production Linked Incentive (PLI) scheme for the Pharmaceutical Sector.

Read more

Brexpiprazole Tablets

Optimus received USFDA Tentative Approval of Brexpiprazole Tablets

Read more

Optimus signed an agreement

Optimus signed an agreement with MPP for providing low-cost molnupiravir to LMICs

Read more

Our Client



Optimus Accreditation